Castle Creek Arbitrage’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,710
Closed -$1.89K 273
2023
Q2
$1.89K Hold
11,710
﹤0.01% 365
2023
Q1
$3.57K Hold
11,710
﹤0.01% 423
2022
Q4
$564 Sell
11,710
-4,990
-30% -$594 ﹤0.01% 520
2022
Q3
$2K Sell
16,700
-8,300
-33% -$1.17K ﹤0.01% 652
2022
Q2
$3K Buy
+25,000
New +$4.87K ﹤0.01% 648

Other funds holding CDIOW

Castle Creek Arbitrage's CDIOW Position: Q3 2023 in Review

Castle Creek Arbitrage sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q3 2023, closing a stake of 11,710 shares — an estimated $1.89K sold.

Castle Creek Arbitrage first reported a position in CDIOW in Q2 2022 and held it in 5 quarters. The position peaked at $3.57K in Q1 2023. 13 funds tracked by Wall St. Rank hold CDIOW as of Q3 2023.

  • Castle Creek Arbitrage reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q3 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 11,710 Cardio Diagnostics Holdings Inc Warrant shares in Q3 2023, an estimated $1.89K.
  • Castle Creek Arbitrage first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q2 2022 and held it in 5 quarters.
  • Castle Creek Arbitrage's Cardio Diagnostics Holdings Inc Warrant position peaked at $3.57K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q3 2023.

Based on Castle Creek Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.